1. Home
  2. DCI vs BIO Comparison

DCI vs BIO Comparison

Compare DCI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCI
  • BIO
  • Stock Information
  • Founded
  • DCI 1915
  • BIO 1952
  • Country
  • DCI United States
  • BIO United States
  • Employees
  • DCI N/A
  • BIO N/A
  • Industry
  • DCI Pollution Control Equipment
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • DCI Industrials
  • BIO Industrials
  • Exchange
  • DCI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • DCI 7.9B
  • BIO 6.0B
  • IPO Year
  • DCI 1987
  • BIO N/A
  • Fundamental
  • Price
  • DCI $71.26
  • BIO $251.56
  • Analyst Decision
  • DCI Hold
  • BIO Strong Buy
  • Analyst Count
  • DCI 3
  • BIO 4
  • Target Price
  • DCI $70.00
  • BIO $324.25
  • AVG Volume (30 Days)
  • DCI 555.7K
  • BIO 406.1K
  • Earning Date
  • DCI 08-27-2025
  • BIO 07-31-2025
  • Dividend Yield
  • DCI 1.69%
  • BIO N/A
  • EPS Growth
  • DCI N/A
  • BIO N/A
  • EPS
  • DCI 2.99
  • BIO N/A
  • Revenue
  • DCI $3,645,600,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • DCI $3.11
  • BIO N/A
  • Revenue Next Year
  • DCI $3.41
  • BIO $3.49
  • P/E Ratio
  • DCI $23.82
  • BIO N/A
  • Revenue Growth
  • DCI 3.26
  • BIO N/A
  • 52 Week Low
  • DCI $57.45
  • BIO $211.43
  • 52 Week High
  • DCI $78.95
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • DCI 63.75
  • BIO 65.86
  • Support Level
  • DCI $68.96
  • BIO $237.42
  • Resistance Level
  • DCI $71.24
  • BIO $254.82
  • Average True Range (ATR)
  • DCI 0.93
  • BIO 7.14
  • MACD
  • DCI 0.18
  • BIO 2.35
  • Stochastic Oscillator
  • DCI 96.49
  • BIO 89.82

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: